NO975366L - Vaksine sammensetning inneholdende polyribosylribitol fosfat og fremgangsmåte for fremstilling derav - Google Patents
Vaksine sammensetning inneholdende polyribosylribitol fosfat og fremgangsmåte for fremstilling deravInfo
- Publication number
- NO975366L NO975366L NO975366A NO975366A NO975366L NO 975366 L NO975366 L NO 975366L NO 975366 A NO975366 A NO 975366A NO 975366 A NO975366 A NO 975366A NO 975366 L NO975366 L NO 975366L
- Authority
- NO
- Norway
- Prior art keywords
- preparation
- composition containing
- vaccine composition
- polyribosylribitol phosphate
- polyribosylribitol
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/102—Pasteurellales, e.g. Actinobacillus, Pasteurella; Haemophilus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55505—Inorganic adjuvants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
- A61K2039/6031—Proteins
- A61K2039/6037—Bacterial toxins, e.g. diphteria toxoid [DT], tetanus toxoid [TT]
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S424/00—Drug, bio-affecting and body treating compositions
- Y10S424/831—Drug, bio-affecting and body treating compositions involving capsular polysaccharide of bacterium, e.g. polyribosyl ribitol phosphate
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR9506417A FR2734484B1 (fr) | 1995-05-24 | 1995-05-24 | Composition vaccinale liquide et procede de fabrication |
PCT/FR1996/000791 WO1996037222A1 (fr) | 1995-05-24 | 1996-05-24 | Composition vaccinale comprenant du polyribosylribitol phosphate et son procede de fabrication |
Publications (3)
Publication Number | Publication Date |
---|---|
NO975366L true NO975366L (no) | 1997-11-21 |
NO975366D0 NO975366D0 (no) | 1997-11-21 |
NO319579B1 NO319579B1 (no) | 2005-08-29 |
Family
ID=9479510
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO19975366A NO319579B1 (no) | 1995-05-24 | 1997-11-21 | Vaksine sammensetning inneholdende hoymolekylaert polyribosylribitolfosfat, og fremgangsmate for fremstilling derav |
NO2011019C NO2011019I2 (no) | 1995-05-24 | 2011-09-19 | Vaksine omfattende antigenet PRP-T koplet til et tetanus anatoksin |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO2011019C NO2011019I2 (no) | 1995-05-24 | 2011-09-19 | Vaksine omfattende antigenet PRP-T koplet til et tetanus anatoksin |
Country Status (26)
Country | Link |
---|---|
US (1) | US6333036B1 (no) |
EP (1) | EP0828511B1 (no) |
JP (1) | JPH11505824A (no) |
KR (1) | KR100404312B1 (no) |
CN (1) | CN1152715C (no) |
AT (1) | ATE207365T1 (no) |
BR (1) | BR9608810C8 (no) |
CA (1) | CA2218764C (no) |
CZ (1) | CZ289810B6 (no) |
DE (2) | DE122011100030I1 (no) |
DK (1) | DK0828511T3 (no) |
EA (1) | EA000411B1 (no) |
ES (1) | ES2162067T3 (no) |
FR (1) | FR2734484B1 (no) |
GR (1) | GR3037011T3 (no) |
HK (1) | HK1017251A1 (no) |
HU (1) | HU223941B1 (no) |
LU (1) | LU91924I2 (no) |
NL (1) | NL300231I2 (no) |
NO (2) | NO319579B1 (no) |
NZ (1) | NZ309829A (no) |
PL (1) | PL185846B1 (no) |
PT (1) | PT828511E (no) |
SK (1) | SK282500B6 (no) |
TR (1) | TR199701424T1 (no) |
WO (1) | WO1996037222A1 (no) |
Families Citing this family (25)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20020054884A1 (en) | 1995-06-23 | 2002-05-09 | Smithkline Beecham Biologicals, Sa | Vaccine composition comprising a polysaccharide conjugate antigen adsorbed onto aluminium phosphate |
US6974581B1 (en) * | 1998-12-15 | 2005-12-13 | Aventis Pasteur Limited | Multi-component vaccine comprising at least two antigens from haemophilus influenzae to protect against disease |
IL145209A0 (en) | 2000-09-06 | 2002-06-30 | Pfizer Prod Inc | Pharmaceutical combinations for the treatment of stroke and traumatic brain injury |
EP1674087A1 (en) | 2000-10-02 | 2006-06-28 | Pfizer Products Inc. | Prophylactic use of n-methyl-d-aspartate (NMDA) antagonists |
FR2828406B1 (fr) * | 2001-08-08 | 2005-06-24 | Aventis Pasteur | Composition vaccinale bivalente havi |
ES2608048T3 (es) | 2002-10-11 | 2017-04-05 | Glaxosmithkline Biologicals Sa | Vacunas polipeptídicas para protección amplia contra linajes meningocócicos hipervirulentos |
CA2514328C (en) | 2003-01-30 | 2020-01-14 | Chiron Srl | Injectable vaccines against multiple meningococcal serogroups |
GB0313916D0 (en) | 2003-06-16 | 2003-07-23 | Glaxosmithkline Biolog Sa | Vaccine composition |
GB0323103D0 (en) | 2003-10-02 | 2003-11-05 | Chiron Srl | De-acetylated saccharides |
DK1961426T3 (da) | 2003-10-02 | 2011-08-08 | Novartis Ag | Kombinationsvacciner mod meningitis |
ATE473967T1 (de) * | 2003-11-26 | 2010-07-15 | Pfizer Prod Inc | Aminopyrazolderivate als gsk-3-inhibitoren |
GB0405787D0 (en) * | 2004-03-15 | 2004-04-21 | Chiron Srl | Low dose vaccines |
GB0409745D0 (en) | 2004-04-30 | 2004-06-09 | Chiron Srl | Compositions including unconjugated carrier proteins |
GB0500787D0 (en) | 2005-01-14 | 2005-02-23 | Chiron Srl | Integration of meningococcal conjugate vaccination |
RU2379052C2 (ru) | 2004-04-30 | 2010-01-20 | Чирон С.Р.Л. | Вакцинация менингококковыми конъюгатами |
CN105147611A (zh) * | 2007-07-26 | 2015-12-16 | 圣诺菲·帕斯图尔有限公司 | 抗原佐剂组合物及其方法 |
GB0818453D0 (en) | 2008-10-08 | 2008-11-12 | Novartis Ag | Fermentation processes for cultivating streptococci and purification processes for obtaining cps therefrom |
PE20100365A1 (es) * | 2008-10-24 | 2010-05-21 | Panacea Biotec Ltd | Novedosas vacunas de combinacion con tos ferina de celulas enteras y metodo para su elaboracion |
PE20100366A1 (es) * | 2008-10-24 | 2010-05-21 | Panacea Biotec Ltd | Novedosas composiciones de vacuna con tos ferina acelular asi como el metodo para su elaboracion |
US7814991B2 (en) * | 2009-01-28 | 2010-10-19 | Gas Technology Institute | Process and apparatus for subterranean drilling |
AU2010227219B2 (en) | 2009-03-24 | 2014-02-27 | Glaxosmithkline Biologicals S.A. | Adjuvanting meningococcal factor H binding protein |
SG10201505374TA (en) * | 2010-03-29 | 2015-08-28 | Novartis Ag | Composition comprising the amyloid beta 1-6 peptide coupled to a virus-like particle and an adjuvant |
CN103442730B (zh) | 2011-01-05 | 2016-08-17 | 巴拉特生物技术国际有限公司 | 组合七价疫苗 |
KR102236498B1 (ko) | 2013-03-08 | 2021-04-06 | 얀센 백신스 앤드 프리벤션 비.브이. | 무세포 백일해 백신 |
EP4327820A1 (en) | 2021-04-20 | 2024-02-28 | KM Biologics Co., Ltd. | Liquid sextuple vaccine composition |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA1209036A (en) * | 1982-08-20 | 1986-08-05 | Joseph S.C. Kuo | Combined haemophilus influenzae and diphtheria, pertussis, tetanus vaccine |
IT1187753B (it) * | 1985-07-05 | 1987-12-23 | Sclavo Spa | Coniugati glicoproteici ad attivita' immunogenica trivalente |
EP0320942A3 (en) * | 1987-12-18 | 1989-10-04 | American Cyanamid Company | Novel polysaccharides novel macromolecular conjugates of the polysaccharides |
GB9202219D0 (en) * | 1992-02-03 | 1992-03-18 | Connaught Lab | A synthetic heamophilus influenzae conjugate vaccine |
DK0835663T3 (da) * | 1992-05-23 | 2010-02-01 | Glaxosmithkline Biolog Sa | Kombinerede vacciner omfattende Hepatitis B overfladeantigen og andre antigener |
-
1995
- 1995-05-24 FR FR9506417A patent/FR2734484B1/fr not_active Expired - Lifetime
-
1996
- 1996-05-24 EP EP96917554A patent/EP0828511B1/fr not_active Expired - Lifetime
- 1996-05-24 CZ CZ19973597A patent/CZ289810B6/cs not_active IP Right Cessation
- 1996-05-24 CN CNB961955821A patent/CN1152715C/zh not_active Expired - Lifetime
- 1996-05-24 DE DE201112100030 patent/DE122011100030I1/de active Pending
- 1996-05-24 PL PL96323457A patent/PL185846B1/pl unknown
- 1996-05-24 SK SK1529-97A patent/SK282500B6/sk not_active IP Right Cessation
- 1996-05-24 DE DE69620271T patent/DE69620271T2/de not_active Expired - Lifetime
- 1996-05-24 WO PCT/FR1996/000791 patent/WO1996037222A1/fr active IP Right Grant
- 1996-05-24 AT AT96917554T patent/ATE207365T1/de active
- 1996-05-24 PT PT96917554T patent/PT828511E/pt unknown
- 1996-05-24 TR TR97/01424T patent/TR199701424T1/xx unknown
- 1996-05-24 US US08/952,602 patent/US6333036B1/en not_active Expired - Lifetime
- 1996-05-24 KR KR1019970708265A patent/KR100404312B1/ko not_active IP Right Cessation
- 1996-05-24 BR BRPI9608810-9C8A patent/BR9608810C8/pt not_active IP Right Cessation
- 1996-05-24 ES ES96917554T patent/ES2162067T3/es not_active Expired - Lifetime
- 1996-05-24 EA EA199700419A patent/EA000411B1/ru not_active IP Right Cessation
- 1996-05-24 HU HU9901432A patent/HU223941B1/hu active Protection Beyond IP Right Term
- 1996-05-24 CA CA2218764A patent/CA2218764C/fr not_active Expired - Lifetime
- 1996-05-24 DK DK96917554T patent/DK0828511T3/da active
- 1996-05-24 JP JP8535452A patent/JPH11505824A/ja not_active Ceased
- 1996-05-24 NZ NZ309829A patent/NZ309829A/xx not_active IP Right Cessation
-
1997
- 1997-11-21 NO NO19975366A patent/NO319579B1/no not_active IP Right Cessation
-
1998
- 1998-10-13 HK HK98111220A patent/HK1017251A1/xx not_active IP Right Cessation
-
2001
- 2001-10-25 GR GR20010401748T patent/GR3037011T3/el unknown
-
2006
- 2006-05-09 NL NL300231C patent/NL300231I2/nl unknown
-
2011
- 2011-09-19 NO NO2011019C patent/NO2011019I2/no not_active IP Right Cessation
- 2011-12-21 LU LU91924C patent/LU91924I2/fr unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO975366D0 (no) | Vaksine sammensetning inneholdende polyribosylribitol fosfat og fremgangsmåte for fremstilling derav | |
IS3753A7 (is) | Endurbætt aðferð og samsetning bóluefnis | |
ATE446107T1 (de) | Immunogenes beta-propionamido-gebundenes polysaccharid-protein konjugat geeignet als impfstoff und hergestellt bei verwendung von n- acryloyliertem polysaccharid | |
AU561978B2 (en) | Haemophilus influenzae b polysaccharide-diptheria toxoid conjugate vaccine | |
YU24391A (sh) | Poboljšana meningokokna polisaharid kon-jugovana vakcina | |
LU91610I2 (fr) | Protéine D et ses dérivés pharmaceutiquement acceptables (SYNFLORIX - Vaccin pneumococcique polysaccharidique conjugé (adsorbé) | |
ATE196605T1 (de) | Gruppe a streptokokkenpolysaccharide immunogen- zusammensetzungen und verfahren | |
EP2277540A3 (en) | Polyanionic polymer adjuvants for haemophilus influenza B saccharide vaccines | |
SE9600716L (sv) | Adhesionsinhibitorer, preparat innehållande desamma och förfarande för framställning därav | |
ES2000140A6 (es) | Procedimiento para preparar vacunas conjugadas no toxicas contra infecciones por bacterias gram-negativas | |
NO974727D0 (no) | Immunogene og immunostimulatoriske oligosakkarid sammensetninger og fremgangsmåter for fremstilling derav | |
AU3313789A (en) | Haemophilus influenza type B oxidized polysaccharide-outer membrane protein conjugate vaccine | |
DK0565590T3 (da) | Adhesin-oligosaccharid-konjugatvaccine mod Haemophilus influenzae | |
EP0320942A3 (en) | Novel polysaccharides novel macromolecular conjugates of the polysaccharides | |
UA27754C2 (uk) | Комбінована педіатрична вакцина, спосіб одночасної комбінованої вакцинації | |
AU6709500A (en) | Trehalose producing cells as vaccines |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
SPCF | Filing of supplementary protection certificate |
Free format text: PRODUCT NAME: PEDIACEL; NAT. REG. NO/DATE: 09-7174 20110321; FIRST REG. NO/DATE: PL06745/0120 20021016 Spc suppl protection certif: 2011019 Filing date: 20110919 |
|
SPCG | Granted supplementary protection certificate |
Free format text: PRODUCT NAME: PEDIACEL; NAT. REG. NO/DATE: 09-7174 20110321; FIRST REG. NO/DATE: PL06745/0120 20021016 Spc suppl protection certif: 2011019 Filing date: 20110919 Extension date: 20171016 |
|
MK1K | Patent expired |